Why Industry Leaders Choose MaxCyte
Our platform is the only non-viral solution currently used in manufacturing a commercial cell therapy. Building on over 25 years of expertise in cell therapy development, it delivers maximum flexibility for a wide range of cargos, cell types, and workflows.
Validated in more than 60 clinical trials, this platform-together with our comprehensive support-consistently helps accelerate development timelines, assisting customers reach the clinic and key inflection points faster.
From Discovery to Commercialization: Partnering at every step
At MaxCyte, we invest in your success from day one, providing on-demand support to establish a GMP-compliant process right from the start, optimizing your workflow beyond electroporation, and accelerating your path to the clinic. Our clinically and commercially proven platform supports advances in cell and gene therapy by streamlining process development and scale-up, de-risking clinical manufacturing, and only after you reach the clinic does our win-win licensing model take effect.
By frontloading our commitment, we demonstrate that we have a vested interest in your success: we only succeed if you do. Our flexible approach consistently delivers value upfront, with a licensing model later that is surprisingly economical for the benefits it provides.
MaxCyte's Best in Class Technology
With decades dedicated to refining electroporation, we have perfected an innovative technology that meets critical goals to streamline cell therapy development: high transfection efficiency, excellent cell viability, continuous scalability, robust reproducibility, and a simplified workflow.
Its user-friendly design and compact footprint enable seamless tech transfer to GMP cell therapy suites, minimizing the risk of operator-related errors.
Your Pathway to Development
MaxCyte's pathway to development seamlessly guides cell and gene therapy innovators through three critical phases: Discovery & Process Development, Clinical Manufacturing, and Commercial Manufacturing. With trusted, proven support, MaxCyte minimizes risk and accelerates timelines by offering scalable technology, regulatory expertise, and tailored guidance.
From on-site optimization to 24/7 manufacturing assistance, MaxCyte's flexible and comprehensive support ensures success from concept to global commercialization, enabling transformative therapies to reach patients faster.
Explore the phases of the Pathway to Development
Learn how MaxCyte accelerates development with comprehensive support.
Ready to learn how we can streamline your cell therapy manufacturing?
Contact our Business Development team Today to Discuss Your Pathway To Development.
